• Antidiuretic Hormone, Serum
  • Primary Hyperoxaluria Gene Mutation Panel
  • Dexamethasone, Serum
  • Clomipramine, Urine
  • Flurazepam, Urine
  • Asymmetric Dimethylarginine, Plasma
  • CD8 Lymphocyte Count
  • Spinocerebellar Ataxia Type 1 (ATXN1) Gene Mutation Analysis
  • Oncomine™ Dx Target Test for Non–Small Cell Lung Cancer (NSCLC) and Other Cancer Treatment Monitoring
  • Parathyroid Hormone, Fine-Needle Aspiration Biopsy (FNAB), Needle Wash
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

References
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.
Loading...